STAT3 and lip and oral cavity carcinoma: To sum up, hesperidin used its anticancer properties with oral cancer cells by inhibiting the expression of programmed cell death ligand 1 (PD-L1) by inactivating the STAT1 and STAT3 signaling molecules [58].